The IFCC webinar on "Evidence-based Laboratory Medicine" was held on 8 September 2021.
It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.
Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.
In this webinar, the speakers covered the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then they discussed how guidelines are implemented using the best available evidence. And finally, they looked at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.
Chair: Prof. Annalise Zemlin (South Africa)
The recorded webinar will be soon available on demand
Certificate of Participation: available for all registrants
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital